ATRC: Summary for AtriCure, Inc. - Yahoo! Canada Finance - Share Prices, Charts, News and more

MORE ON ATRC

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

AtriCure, Inc. (NGM:ATRC) Delayed quote data

Last Trade:	5.45 USD
Trade Time:	Nov 24
Change:	0.00 (0.00%)
Prev Close:	5.45
Open:	N/A
Bid:	5.17 x 100
Ask:	5.93 x 100
1y Target Est:	6.13

Day's Range:	N/A - N/A
52wk Range:	1.00 - 6.08
Volume:	0
Avg Vol (3m):	35,531.8
Market Cap:	83.46M
P/E (ttm):	N/A
EPS (ttm):	-1.20
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Add ATRC to Portfolio

Download Data

HEADLINES

•	AtriCure to Present at Piper Jaffray Healthcare Conference
	Business Wire (Mon, Nov 23)

•	ATRICURE, INC. Financials
	EDGAR Online Financials (Fri, Nov 13)

•	ATRICURE, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Mon, Nov 9)

•	New Star Analyst Rankings for AtriCure, Inc.
	StarMine (Thu, Nov 5)

•	AtriCure upgraded by Piper Jaffray
	Briefing.com (Thu, Nov 5)

•	[$$] Corporate Watch
	at The Wall Street Journal Online (Wed, Nov 4)

•	AtriCure, Inc. Q3 2009 Earnings Call Transcript
	at Seeking Alpha (Wed, Nov 4)

•	AtriCure suit settlement boosts stock
	at bizjournals.com (Wed, Nov 4)

•	ATRICURE INC Earnings Call scheduled for 10:00 am ET today
	CCBN (Wed, Nov 4)

•	ATRICURE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements
	EDGAR Online (Wed, Nov 4)

More Headlines for ATRC...

ANALYST

EPS Est (next year) (Dec-09) :	-0.34
EPS Est (in 2 years) (Dec-10) :	-0.10
Avg Rec (current)*:	2.2
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

AtriCure, Inc., a medical device company, engages in the development, manufacture, and sale of cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac tissue.

Full Company Profile

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

AtriCure, Inc. (ATRC)